Guided Therapeutics, Inc. (GTHP)
USD 0.07
(-31.5%)
USD 0.07
(-31.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.74 Million | -1.47 Million | -1.59 Million | -1.87 Million | -806 Thousand | -1.36 Million |
| Net Income | -3.48 Million | -4.34 Million | -2.07 Million | -279 Thousand | -1.92 Million | 1.01 Million |
| Depreciation & Amortization | 85 Thousand | 72 Thousand | 83 Thousand | - | 21 Thousand | 27 Thousand |
| Deferred income taxes | 44 Thousand | - | 223 Thousand | - | -380 Thousand | -4.27 Million |
| Stock-based compensation | 1.8 Million | 1.38 Million | 228 Thousand | 310 Thousand | 8000.00 | 44 Thousand |
| Change in working capital | -105 Thousand | 549 Thousand | 78 Thousand | -783 Thousand | 1.26 Million | 985 Thousand |
| Other non-cash items | -87 Thousand | 2.06 Million | -133 Thousand | -1.12 Million | 197 Thousand | 835 Thousand |
| Investing Cash Flow | - | -31 Thousand | -14 Thousand | -1000.00 | - | - |
| Investments in PPE | - | -31 Thousand | -14 Thousand | -1000.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 24 Thousand | 3.18 Million | 2.06 Million | 1.15 Million | 1.7 Million | 1.36 Million |
| Debt repayment | -412 Thousand | -540 Thousand | -92 Thousand | -1.1 Million | -281 Thousand | -1.38 Million |
| Dividends payments | - | - | - | - | - | -116 Thousand |
| Common Stock Repurchased | - | - | -125 Thousand | - | - | - |
| Common Stock Issuance | 436 Thousand | 3.72 Million | 2.1 Million | 1.74 Million | 635 Thousand | 170 Thousand |
| Other Financing Activities | 24 Thousand | 3.18 Million | 312 Thousand | 519 Thousand | 1.35 Million | -22 Thousand |
| Accounts receivables | -3000.00 | 16 Thousand | -22 Thousand | -23 Thousand | 1.14 Million | -10 Thousand |
| Accounts payables | 43 Thousand | 123 Thousand | -229 Thousand | -372 Thousand | 20 Thousand | -6000.00 |
| Inventory | -84 Thousand | -58 Thousand | 33 Thousand | -483 Thousand | 66 Thousand | 151 Thousand |
| Other working capital | -61 Thousand | 468 Thousand | 296 Thousand | 95 Thousand | 35 Thousand | 850 Thousand |
| Cash at beginning of period | 2.31 Million | 643 Thousand | 182 Thousand | 899 Thousand | - | 1000.00 |
| Cash at end of period | 591 Thousand | 2.31 Million | 643 Thousand | 182 Thousand | 899 Thousand | - |
| Capital Expenditure | - | -31 Thousand | -14 Thousand | -1000.00 | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.72 Million | 1.67 Million | 461 Thousand | -717 Thousand | 899 Thousand | -1000.00 |
| Free Cash Flow | -1.74 Million | -1.5 Million | -1.6 Million | -1.87 Million | -806 Thousand | -1.36 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -709 Thousand | -402 Thousand | -386 Thousand | -3.48 Million | -677 Thousand | -1.55 Million |
| Depreciation & Amortization | 24 Thousand | 23 Thousand | 22.05 Thousand | 85 Thousand | 21 Thousand | 22 Thousand |
| Deferred income taxes | - | - | 197.89 Thousand | 44 Thousand | -17 Thousand | -50 Thousand |
| Stock-based compensation | 30 Thousand | 30 Thousand | -54 Thousand | 1.8 Million | 177 Thousand | 1.11 Million |
| Change in working capital | 425 Thousand | 234 Thousand | 170 Thousand | -105 Thousand | -18 Thousand | -45 Thousand |
| Other non-cash items | -310 Thousand | 168 Thousand | -285.94 Thousand | -87 Thousand | 41 Thousand | -384 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 44 Thousand | -46 Thousand | 196 Thousand | 24 Thousand | -154 Thousand | -41 Thousand |
| Debt repayment | -44 Thousand | -46 Thousand | -45 Thousand | -412 Thousand | -154 Thousand | -41 Thousand |
| Dividends payments | - | -39 Thousand | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 57 Thousand | 241 Thousand | 436 Thousand | - | - |
| Other Financing Activities | 44 Thousand | -64 Thousand | 196 Thousand | 24 Thousand | -154 Thousand | -41 Thousand |
| Accounts receivables | 3000.00 | 1000.00 | 43 Thousand | -3000.00 | -43 Thousand | -2000.00 |
| Accounts payables | 401 Thousand | -78 Thousand | 173 Thousand | 43 Thousand | 43 Thousand | -11 Thousand |
| Inventory | - | - | 15 Thousand | -84 Thousand | -74 Thousand | 11 Thousand |
| Other working capital | 21 Thousand | 311 Thousand | -18 Thousand | -61 Thousand | 56 Thousand | -43 Thousand |
| Cash at beginning of period | 445 Thousand | 591 Thousand | 731 Thousand | 2.31 Million | 1.35 Million | 1.83 Million |
| Cash at end of period | 275 Thousand | 445 Thousand | 591 Thousand | 591 Thousand | 731 Thousand | 1.35 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -170 Thousand | -146 Thousand | -140 Thousand | -1.72 Million | -627 Thousand | -479 Thousand |
| Free Cash Flow | -214 Thousand | -100 Thousand | -336 Thousand | -1.74 Million | -473 Thousand | -438 Thousand |
NLY-PF
GOGL
028300
KALAMANDIR
004370
BION